IMU Insider Trading (Imugene)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$630,000.00
Insider Selling (Last 12 Months): A$4,123,782.26
Imugene Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Warning: The Last Value Play Gone After August?
From Oxford Club | Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.
But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
Imugene Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/7/2022 | Jens Eckstein | Insider | Sell | 2,100,000 | A$0.30 | A$630,000.00 | | |
| 12/13/2021 | Paul Hopper | Insider | Sell | 1,248,900 | A$0.49 | A$611,961.00 | | |
| 10/22/2021 | Paul Hopper | Insider | Issued | 1,248,600 | A$0.02 | A$18,729.00 | | |
| 7/1/2021 | Lesley Russell | Insider | Buy | 15,000,000 | A$0.04 | A$630,000.00 | | |
| 5/28/2021 | Leslie (Mi Ok) Chong | Insider | Exercise | 13,844,444 | A$0.05 | A$622,999.98 | | |
| 5/25/2021 | Leslie (Mi Ok) Chong | Insider | Sell | 4,485,889 | A$0.37 | A$1,646,321.26 | | |
| 5/21/2021 | Charles Walker | Insider | Sell | 3,500,000 | A$0.35 | A$1,235,500.00 | | |
| 12/22/2020 | Leslie Chong | Insider | Exercise | 98,765 | A$0.04 | A$3,950.60 | | |
| 12/16/2020 | Axel Hoos | Insider | Exercise | 15,000,000 | A$0.04 | A$615,000.00 | | |
| 8/10/2020 | Charles Walker | Insider | Sell | 4,500,000 | A$0.06 | A$261,000.00 | | |
| 8/4/2020 | Leslie Chong | Insider | Buy | 27,000,000 | A$0.02 | A$405,000.00 | | |
| 3/23/2020 | Charles Walker | Insider | Buy | 172,500 | A$0.02 | A$2,760.00 | | |
| 3/16/2020 | Leslie Chong | Insider | Buy | 475,240 | A$0.02 | A$8,554.32 | | |
| 3/12/2020 | Leslie Chong | Insider | Buy | 400,000 | A$0.02 | A$8,800.00 | | |
The Incredible Dividend Map... Where Stocks Yield 26% a Year!
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned?
The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
SEC Filings (Institutional Ownership Changes) for Imugene (ASX:IMU)
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors; and has a strategic collaboration with Eureka Therapeutics, Inc. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.
Read More on Imugene
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
12,699,963 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Imugene?
Imugene's top insider investors include:
- Axel Hoos (Insider)
- Charles Walker (Insider)
- Jens Eckstein (Insider)
- Lesley Russell (Insider)
- Leslie (Mi Ok) Chong (Insider)
- Leslie Chong (Insider)
- Paul Hopper (Insider)
Learn More about top insider investors at Imugene.
